JANX
$17.20+2.75%
Janux Therapeutics Inc.Stock · HealthcareRussell 2000 · 0.02% of IWMRussell 3000 · 0.001% of IWVUS Stock Market · 0.0008% of VTI
JANX financial statements
The full income statement, balance sheet, and cash-flow statement for Janux Therapeutics Inc. (JANX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 52.2M2024-09 52.5M2024-12 59.1M2025-03 59.2M2025-06 60.1M2025-09 60.1M2025-12 60.8M2026-03 61.0M2026-06 61.1M+17.2% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 10.0M-5.6% | 10.6M+31.0% | 8.08M-6.1% | 8.61M+136.8% | 3.64M | |
| Research & development | 126M+84.1% | 68.4M+24.5% | 54.9M+2.8% | 53.4M+103.7% | 26.2M+762.8% | |
| Selling, general & administrative | 41.8M+1.8% | 41.0M+57.0% | 26.1M+17.4% | 22.3M+115.5% | 10.3M+473.2% | |
| General & administrative | 41.8M+1.8% | 41.0M+57.0% | 26.1M+17.4% | 22.3M+115.5% | 10.3M+473.2% | |
| Operating income | -158M-59.5% | -98.8M-35.4% | -73.0M-8.8% | -67.1M-103.7% | -32.9M-579.9% | |
| Other non-operating income | 44.0M+47.5% | 29.9M+103.3% | 14.7M+264.2% | 4.03M+1468.9% | 257K+113.2% | |
| Income tax | 0.00 | 0.00 | 0.00 | — | — | |
| Net income | -114M-64.7% | -69.0M-18.4% | -58.3M+7.6% | -63.1M-93.0% | -32.7M-381.6% | |
| -$1.83-43.0% | -$1.28+3.0% | -$1.32+13.2% | -$1.52-9.4% | -$1.39 | ||
| EPS (basic) | -$1.83-43.0% | -$1.28+3.0% | -$1.32+13.2% | -$1.52-9.4% | -$1.39 | |
| Weighted-avg shares (basic) | 62.0M+15.3% | 53.8M+22.1% | 44.0M+6.1% | 41.5M+76.2% | 23.5M+9967.5% | |
| Weighted-avg shares (diluted) | 62.0M+15.3% | 53.8M+22.1% | 44.0M+6.1% | 41.5M+76.2% | 23.5M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 976M-5.6% | 1.03B+196.0% | 349M+5.1% | 332M-11.8% | 377M+2247.3% | ||
| Cash & equivalents | 52.3M-87.8% | 431M+2142.2% | 19.2M-62.7% | 51.4M+44.5% | 35.6M+355.4% | |
| Short-term investments | 914M+53.8% | 595M+83.0% | 325M+17.9% | 276M-18.8% | 339M | |
| Accounts receivable | 0.00 | — | 0.00 | 0.00 | 0.00-100.0% | |
| Prepaid expenses | 9.32M+9.7% | 8.49M+62.9% | 5.21M-3.9% | 5.42M+164.0% | 2.05M+724.9% | |
| 1.00B-5.6% | 1.06B+179.0% | 380M+4.5% | 364M-4.2% | 380M+2242.1% | ||
| Property, plant & equipment | 3.85M-20.8% | 4.86M-30.5% | 7.00M-1.2% | 7.09M+401.8% | 1.41M+811.0% | |
| Operating lease right-of-use | 18.4M-4.6% | 19.3M-7.4% | 20.8M-6.5% | 22.3M+11942.7% | 185K | |
| Other non-current assets | 2.61M-9.6% | 2.88M+14.9% | 2.51M+80.5% | 1.39M+254.6% | 392K | |
| 25.0M+43.2% | 17.5M+34.0% | 13.0M-21.0% | 16.5M+29.0% | 12.8M+302.3% | ||
| Accounts payable | 4.97M+23.5% | 4.03M+66.1% | 2.42M+12.3% | 2.16M-12.2% | 2.46M+474.3% | |
| Accrued liabilities | 17.6M+50.9% | 11.7M+58.2% | 7.39M-9.7% | 8.18M+116.4% | 3.78M+403.2% | |
| Deferred revenue | 0.00 | 0.00-100.0% | 1.71M-68.5% | 5.41M+4.7% | 5.16M+164.8% | |
| Current lease liability | 2.39M+36.8% | 1.75M+15.3% | 1.52M+98.8% | 763K+293.3% | 194K | |
| 44.7M+15.5% | 38.7M+7.4% | 36.1M-16.7% | 43.3M+220.6% | 13.5M+46.2% | ||
| Deferred revenue (non-current) | 0.00 | — | 0.00-100.0% | 2.22M+217.3% | 700K-88.4% | |
| Non-current lease liability | 19.7M-7.2% | 21.3M-7.6% | 23.0M-6.2% | 24.5M | 0.00 | |
| Operating lease liability (total) | 22.1M-3.8% | 23.0M-6.2% | 24.5M-3.0% | 25.3M+12943.8% | 194K | |
| 957M-6.4% | 1.02B+197.0% | 344M+7.4% | 321M-12.4% | 366M+2602.6% | ||
| Preferred stock | 0.00 | — | — | — | — | |
| Common stock | 60.0K+1.7% | 59.0K+28.3% | 46.0K+9.5% | 42.0K+2.4% | 41.0K+4000.0% | |
| Additional paid-in capital | 1.30B+3.6% | 1.26B+145.6% | 512M+18.4% | 433M+4.5% | 414M | |
| Retained earnings | -351M-47.8% | -238M-40.9% | -169M-52.8% | -110M-133.0% | -47.4M-221.7% | |
| Accumulated other comprehensive income | 4.32M+99.5% | 2.16M+225.3% | 665K+143.3% | -1.53M-468.5% | -270K | |
| Total liabilities & equity | 1.00B-5.6% | 1.06B+179.0% | 380M+4.5% | 364M-4.2% | 380M+2242.1% | |
| Common shares issued | 60.4M+2.2% | 59.1M+27.7% | 46.3M+11.0% | 41.7M+0.1% | 41.6M+3209.4% | |
| Common shares outstanding | 60.4M+2.2% | 59.1M+27.7% | 46.3M+11.1% | 41.6M+0.9% | 41.2M+3840.7% | |
| Shares outstanding (cover) | 60.8M+2.9% | 59.1M+14.4% | 51.7M+23.5% | 41.8M+0.5% | 41.6M | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -82.2M-87.7% | -43.8M+13.4% | -50.6M-17.8% | -42.9M-152.8% | -17.0M-288.6% | ||
| Depreciation & amortization | 2.03M-1.5% | 2.06M+5.4% | 1.96M+132.5% | 841K+644.2% | 113K+769.2% | |
| Share-based compensation | 40.2M+21.8% | 33.0M+65.1% | 20.0M+16.3% | 17.2M+149.0% | 6.91M+9497.2% | |
| Deferred income taxes | — | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in receivables | — | — | — | 0.00+100.0% | -8.00M-200.0% | |
| Change in payables | 977K-38.3% | 1.58M+471.8% | 277K+194.2% | -294K-113.7% | 2.14M+15178.6% | |
| -301M-16.6% | -258M-526.4% | -41.2M-170.7% | 58.3M+117.1% | -341M | ||
| Capital expenditure | 1.04M+190.5% | 359K-80.6% | 1.85M-71.3% | 6.45M+334.9% | 1.48M | |
| Free cash flow | -83.3M-88.5% | -44.2M+15.7% | -52.4M-6.2% | -49.4M-167.5% | -18.5M-322.5% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 4.95M-99.3% | 713M+1097.7% | 59.5M+11809.6% | 500K-99.9% | 387M+3254.1% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 839M-73.5% | 3.16B+538.8% | 495M-9.7% | 549M-33.2% | 821M | |
| P/S | 83.9×-71.9% | 298.9×+410.8% | 58.5×-21.3% | 74.3×-67.1% | 225.8× | |
| P/B | 0.9×-71.6% | 3.1×+117.9% | 1.4×-14.2% | 1.7×-26.2% | 2.2× | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: JANX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all JANX filings on SEC EDGAR → Not investment advice.